
Photo taken from ESMO/LinkedIn
Jul 22, 2024, 11:36
Breaking Science in Gastrointestinal Cancers with Michel P. Ducreux – ESMO
ESMO shared on LinkedIn:
“For ESMO members: Breaking Science in Gastrointestinal Cancers.
Michel P. Ducreux presents his findings on Sequences of regorafenib and trifluridine/tipiracil after failure of standard therapies for mCRC.
Explore this video and the entire series on OncologyPRO now.”
Source: ESMO/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 22, 2025, 03:56
Feb 22, 2025, 03:52
Feb 22, 2025, 03:21
Feb 22, 2025, 03:18
Feb 22, 2025, 02:44
Feb 22, 2025, 02:36
Feb 21, 2025, 15:06